Literature DB >> 3034068

Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.

M Estrin, S A Huber.   

Abstract

Male BALB/c mice inoculated with 6 X 10(4) plaque-forming units (pfu) coxsackievirus, group B, type 3 (CVB3), develop myocarditis within 7 days. Two cytolytic T lymphocyte (CTL) populations arise in infected animals. One population belongs to the Lyt 2+ T (cytolytic/suppressor) lymphocyte subset and reacts specifically with uninfected heart cells (autoreactive CTLs, ACTLs), whereas the other belongs to the L3T4+ T (helper) lymphocyte subset and reacts with infected targets (virus-specific CTLs, VSCTLs). Although both immune T lymphocyte populations can induce cardiac inflammation in vivo, ACTLs predominantly cause tissue injury. VSCTL generation can be inhibited by either anti-Tac (antibody to the interleukin 2 [IL-2] receptor) or anti-Iad but not by anti-IAk, indicating that this response is probably both IL-2-dependent and Class II (major histocompatibility complex [MHC] antigen restricted. ACTL generation is independent of IL-2, because neither anti-Tac or cyclosporin A inhibit this response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034068      PMCID: PMC1899756     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.

Authors:  J F Woodruff; J J Woodruff
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

2.  Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: evidence for involvement of mononuclear inflammatory cells in host defense.

Authors:  J F Woodruff
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

3.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.

Authors:  B Maisch; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

4.  Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.

Authors:  R B Nussenblatt; A G Palestine; C C Chan
Journal:  Am J Ophthalmol       Date:  1983-09       Impact factor: 5.258

5.  Diagnosis and classification of myocarditis by endomyocardial biopsy.

Authors:  J J Fenoglio; P C Ursell; C F Kellogg; R E Drusin; M B Weiss
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

6.  Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes.

Authors:  R D Garman; D P Fan
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Inhibition of T-cell activity by cyclosporin A.

Authors:  L Andrus; K J Lafferty
Journal:  Scand J Immunol       Date:  1981-05       Impact factor: 3.487

8.  Evidence for an interleukin-independent pathway for human lymphocyte activation.

Authors:  G A Koretzky; R P Daniele; W C Greene; P C Nowell
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice.

Authors:  S A Huber; L P Job
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  15 in total

Review 1.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Role of cytotoxic T cells in experimental myocarditis.

Authors:  N Van Houten; S A Huber
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.

Authors:  G R Birchfield; J H Ward; B G Redman; L Flaherty; W E Samlowski
Journal:  West J Med       Date:  1990-06

4.  Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Robert P Chervenak; Ikuo Tsunoda
Journal:  Future Virol       Date:  2012-06       Impact factor: 1.831

5.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 6.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice.

Authors:  C Kishimoto; Y Hiraoka; H Takada; M Kurokawa; H Ochiai
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

8.  Pathologic findings in the hearts of patients with acquired immunodeficiency syndrome.

Authors:  M Klima; S M Escudier
Journal:  Tex Heart Inst J       Date:  1991

Review 9.  The heart of the matter: protection of the myocardium from T cells.

Authors:  Andrew H Lichtman
Journal:  J Autoimmun       Date:  2013-06-28       Impact factor: 7.094

10.  Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.

Authors:  P A Lodge; M Herzum; J Olszewski; S A Huber
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.